Simbec-Orion Group
Private Company
Total funding raised: $45M
Overview
Simbec-Orion Group is a long-established, mid-sized, and privately-held clinical research organization (CRO) headquartered in Cardiff, UK. It provides end-to-end clinical development services, distinguishing itself through a flexible, specialist approach and deep expertise in challenging therapeutic areas like rare diseases, oncology, CNS, and respiratory. The company operates globally, leveraging its own clinical pharmacology unit and central laboratory to offer integrated, full-service solutions to biopharma clients. Its business model is entirely service-based, generating revenue from contracted research and consulting work.
Technology Platform
Integrated CRO service platform featuring an in-house Clinical Pharmacology unit for early-phase studies, a Central Laboratory for bioanalytical and safety testing, and expertise in advanced data analytics (e.g., AI causal modeling).
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Operates in the highly competitive global CRO market, competing against large, full-service players (e.g., IQVIA, ICON) with greater scale and resources, as well as smaller, niche CROs. Differentiates through a mid-size, agile structure, deep therapeutic specialization in complex areas (rare diseases, oncology), and an integrated service model combining clinical operations with owned clinical pharmacology and central lab units.